| Page 1938 | Kisaco Research
 

Mark Aspinall O’Dea

EMEA Business Development Manager
Retogenix

Mark Aspinall O’Dea

EMEA Business Development Manager
Retogenix

Mark Aspinall O’Dea

EMEA Business Development Manager
Retogenix
 
26-27 Feb 2019
200 Aldersgate, St. Pauls, London, UK
Animal Health Investment Europe is a premier investment forum showcasing the most exciting investment opportunities in animal health and nutrition and connecting those businesses with financial investors and strategic corporate partners. To complement our investment pitches, we host CEO-level discussions that address the trends and market dynamics of the animal health industry, across all species. A key element of the investment forum is the full use of a our 1-on-1 private meeting platform, available to all attendees. Going forward, as the industry experiences a shift towards the detection and prevention of disease, we are increasingly focused on presenting innovation in nutritional health, data analytics, sensors and diagnostics.This year, for the first time, we will be categorising our presenting companies according to the level of investment they’re seeking, early, mid and late stage.
Agenda from Human Biotech & Animal Health USA 2018
 
Human Biotech Animal Health EU
18-19 Jun 2018
Amsterdam, The Netherlands
Join the first ever conference series connecting human biotechs with the animal health industry. Following the event's hugely successful launch in Boston, USA, Human Biotech & Animal Health Business Partnering Summit is now coming to Europe. Traditionally, innovation in veterinary health has come from parent human pharmaceutical R&D pipelines. Within an increasingly independent and mature animal health industry, new routes to innovation are being established. There are a multitude of exceptional technologies in the human health field that could be used in animal health, but currently there is limited contact between the two areas – this summit aims to connect the two industries.
 

Josh Goldin

Alliance Consumer Growth

Josh Goldin

Alliance Consumer Growth

Josh Goldin

Alliance Consumer Growth
 

David Beno

Chief Scientific Officer
Xeno Biosciences

David Beno

Chief Scientific Officer
Xeno Biosciences

David Beno

Chief Scientific Officer
Xeno Biosciences
Microbiome Event Series Calendar
 

Ava Firth

Director of R&D
Tonisity

Ava is a veterinarian and board-certified specialist in veterinary emergency and critical care. Originally from Ohio, USA, she has held both private practice and university positions in the USA, Australia and the United Kingdom, specialising in small animal emergencies and lecturing internationally.

Ava Firth

Director of R&D
Tonisity

Ava Firth

Director of R&D
Tonisity

Ava is a veterinarian and board-certified specialist in veterinary emergency and critical care. Originally from Ohio, USA, she has held both private practice and university positions in the USA, Australia and the United Kingdom, specialising in small animal emergencies and lecturing internationally.

Her interest in critical care nutrition, particularly microenteral nutrition, led to her position as Director of Research and Development for Tonisity. She is responsible for designing and coordinating research and trials, as well as managing the product development pipeline and regulatory affairs.

 

Tim McAllister

Principle Scientist Research
Agriculture and Agri-Food Canada

Dr. Tim McAllister grew up on his parents’ cow/calf farm in Innisfail, AB. He obtained a B.Sc. (Agr) and M.Sc. from the University of Alberta in Edmonton, and a Ph.D. (with distinction) in ruminant nutrition and microbiology from the University of Guelph, ON. He accepted an NSERC post-doctoral fellowship at the University of Calgary in 1991, and joined Agriculture and Agri-Food Canada in Lethbridge, AB in 1992. Dr. McAllister has been a research scientist in Rumen Microbiology, Feed and Nutrition since 1997.

Tim McAllister

Principle Scientist Research
Agriculture and Agri-Food Canada

Tim McAllister

Principle Scientist Research
Agriculture and Agri-Food Canada

Dr. Tim McAllister grew up on his parents’ cow/calf farm in Innisfail, AB. He obtained a B.Sc. (Agr) and M.Sc. from the University of Alberta in Edmonton, and a Ph.D. (with distinction) in ruminant nutrition and microbiology from the University of Guelph, ON. He accepted an NSERC post-doctoral fellowship at the University of Calgary in 1991, and joined Agriculture and Agri-Food Canada in Lethbridge, AB in 1992. Dr. McAllister has been a research scientist in Rumen Microbiology, Feed and Nutrition since 1997. His research focuses on microbiology, nutrition and beef production and on food and environmental safety issues related to livestock production, strategies for mitigation of Escherichia coli O157:H7, prion inactivation within the environment, and more recently, studies of antimicrobial resistance in bacteria in feedlots. He also has extensive research experience in GHG emissions within animals from manure and the impact of manure handling procedures, such as composting, on emissions. Dr. McAllister has conducted research to examine microbiological and nutritional approaches for mitigating ruminal methanogenesis, and emission of nitrous oxide and methane during composting, using strategies including the use of plant extracts, methanogen inhibitors and dietary formulations to limit methane production. He is the author or co-author of over 520 peer-reviewed scientific papers and 60 reviews, as well as 800 abstracts and conference proceedings, and over 100 final reports for collaborative research projects. Dr. McAllister has been recognized internationally for his leadership role and significant contributions to agricultural research and innovation in the areas of ruminant nutrition/microbiology and molecular biology as they apply to animal health, environmental health and food quality for the benefit of the agricultural industry in Alberta, Canada, and beyond.